Clinical trial

Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes

NCT02380521

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-01-01

PhasePHASE4

Study timeline

Study start (unknown)2015-01-01Date precision: month

Registry last updated2016-11-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

Exenatide once weekly (BYDUREON™)DRUG

Sponsors & collaborators

University of Palermolead sponsor

AstraZenecacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02380521 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.